May 27th 2016EP. 1: Complications of Diabetes and Role of Insulin Resistance in Metabolic Syndrome
May 27th 2016EP. 2: Comparison of Guidelines From ADA and AACE
May 27th 2016EP. 3: How Does the Potential for Weight Gain Influence Choice of Therapies?
May 27th 2016EP. 4: Variables Involved When Adding Medications to Treat Diabetes
May 27th 2016EP. 5: The Influence of Lipid Guidelines on Real-World Practice Patterns
May 27th 2016EP. 6: Alternatives to Add-On Therapy for T2D and Hyperlipidemia
May 27th 2016EP. 7: WellCare's Initiatives To Improve Care for Members With Diabetes
May 27th 2016EP. 8: Partnering With Providers to Prevent or Delay Complications Related to Diabetes
May 27th 2016EP. 9: The Role of Managed Care in Identifying and Counseling Patients With Prediabetes
May 27th 2016EP. 10: Addressing the Effect of Polypharmacy on Medication Adherence
May 27th 2016EP. 11: Role of Clinical Practice Guidelines in the Management of Diabetes and Diabetes-Related Complications
May 27th 2016EP. 12: Considerations Regarding Statin Therapy
May 27th 2016EP. 13: Management of Hyperlipidemia in Patients With Liver Impairment or Renal Impairment
May 27th 2016EP. 14: Advantages of Medications that Treat Multiple Conditions
May 27th 2016EP. 15: Updates to Treatment Guidelines: Effects on Payers
May 27th 2016EP. 16: Major Cost Drivers in T2D Management
May 27th 2016EP. 17: Role of Early Intervention in Preventing Progression to T2D
May 27th 2016EP. 18: How Drug Cost Influences Drug Selection
May 27th 2016EP. 19: Impact of Cost on Patients' Access to Treatment
May 27th 2016EP. 20: An Increased Emphasis on Individual Risk Factors and Goals
May 27th 2016EP. 21: The Role of PCSK9 Inhibitors for Patients with Hyperlipidemia
May 27th 2016EP. 22: Role of the Health Plan in Providing Support to Members With Diabetes
May 27th 2016EP. 23: The Potential Role of PCSK9 Inhibitors for Patients With Hyperlipidemia
May 27th 2016EP. 24: Complexities in Diabetes Care in 2017
May 27th 2016EP. 25: Diabetes: Shifting Mindset for Cardiovascular Benefits
May 27th 2016EP. 26: Practical Implications of the CANVAS Trial
May 27th 2016EP. 27: Understanding the Safety Data in CANVAS
May 27th 2016EP. 28: GLP-1 Receptor Agonists and Cardiovascular Benefit
May 27th 2016EP. 29: Examining Cardiovascular Outcomes Trials
May 27th 2016EP. 30: Raising the Bar on Cardiovascular Benefit
